Cargando…

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?

Detalles Bibliográficos
Autor principal: Kim, Eun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960970/
https://www.ncbi.nlm.nih.gov/pubmed/33716221
http://dx.doi.org/10.5009/gnl210098
_version_ 1783665155032219648
author Kim, Eun Soo
author_facet Kim, Eun Soo
author_sort Kim, Eun Soo
collection PubMed
description
format Online
Article
Text
id pubmed-7960970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-79609702021-03-24 Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis? Kim, Eun Soo Gut Liver Editorial Editorial Office of Gut and Liver 2021-03-15 2021-03-15 /pmc/articles/PMC7960970/ /pubmed/33716221 http://dx.doi.org/10.5009/gnl210098 Text en Copyright © Gut and Liver. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kim, Eun Soo
Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title_full Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title_fullStr Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title_full_unstemmed Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title_short Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
title_sort infliximab versus adalimumab, which one is better for ulcerative colitis?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960970/
https://www.ncbi.nlm.nih.gov/pubmed/33716221
http://dx.doi.org/10.5009/gnl210098
work_keys_str_mv AT kimeunsoo infliximabversusadalimumabwhichoneisbetterforulcerativecolitis